Last reviewed · How we verify

NCT05105074

Does the Use of Intrathecal Morphine Increase the Length of Hospital Stay in Fast Track Orthopedic Procedures?

Completed NA Last updated 12 May 2022
What this trial tests

NA trial testing Intrathecal Morphine in Arthropathy of Knee in 104 participants. Completed in 30 October 2021.

Timeline
19 January 2019
Primary endpoint
1 October 2021
30 October 2021

Quick facts

Lead sponsorSamuel Lunenfeld Research Institute, Mount Sinai Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposesupportive care
Enrollment104
Start date19 January 2019
Primary completion1 October 2021
Estimated completion30 October 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Who can join

Adults 18 to 85, any sex, with Arthropathy of Knee or Arthropathy of Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a clinical trial of intrathecal morphine for patients Patient with primary as well as revision knee and hip arthroplasty under regional anesthesia. This study would include a total of 134 patients. It is the intention to randomize these patients postoperatively into 2 groups of patients: Group 1 - Patients will receive intrathecal morphine 100 mcg in addition to the standard dose of bupivacaine and 15 mcg of fentanyl for spinal anesthesia. Group 2 - Patients will not receive intrathecal morphine. Patients will receive only bupivacaine and 15 mcg of fentanyl for spinal anesthesia. It is postulated that the use of intrathecal morphine may be associated with an increase length of stay in the hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Intrathecal Morphine

Trials testing the same drug.

Other recruiting trials for Arthropathy of Knee

Currently open trials in the same condition.

Other Samuel Lunenfeld Research Institute, Mount Sinai Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05105074.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing